XML 25 R14.htm IDEA: XBRL DOCUMENT v3.21.2
Note 8 - Stock-based Compensation Expense
9 Months Ended
Sep. 30, 2021
Notes to Financial Statements  
Share-based Payment Arrangement [Text Block]

NOTE 8:         STOCK-BASED COMPENSATION EXPENSE

 

 

The Company recorded, as part of general and administrative expense, $81,000 and $193,000 during the three and nine months ended September 30, 2021, respectively, and during the three and nine months ended September 30, 2020, $65,000 and $206,000, respectively, for the cost of employee and director services received in exchange for equity instruments based on the grant-date fair value of those instruments.

 

A summary of the stock option activity related to the 2001 Stock Option Plans, the 2007 Share Incentive Plan and the 2016 Share Incentive Plan for the period from January 1, 2021 through September 30, 2021 are as follows:

 

2001 Non-Qualified Stock Option Plan

                     
  

Beginning

  

Granted

  

Exercised

  

Canceled

  

Ending

     
  

Balance

  

During

  

During

  

During

  

Balance

     
  

Outstanding

  

Period

  

Period

  

Period

  

Outstanding

  

Exercisable

 
                         

Number of shares

  7,000   -   -   (7,000)  -   - 

Weighted average exercise price per share

 $7.90   -   -  $7.90   -   - 
                         

2007 Share Incentive Plan

                        
  

Beginning

  

Granted

  

Exercised

  

Canceled

  

Ending

     
  

Balance

  

During

  

During

  

During

  

Balance

     
  

Outstanding

  

Period

  

Period

  

Period

  

Outstanding

  

Exercisable

 
                         

Number of shares

  345,000   -   -   -   345,000   325,000 

Weighted average exercise price per share

 $12.33   -   -   -  $12.33  $12.46 
                         

2016 Share Incentive Plan

                        
  

Beginning

  

Granted

  

Exercised

  

Canceled

  

Ending

     
  

Balance

  

During

  

During

  

During

  

Balance

     
  

Outstanding

  

Period

  

Period

  

Period

  

Outstanding

  

Exercisable

 
                         

Number of shares

  65,000   328,500   -   -   393,500   65,000 

Weighted average exercise price per share

 $5.94  $4.13   -   -  $4.43  $5.94 

 

For the nine months ended September 30, 2021, the Company granted 328,500 stock options, vesting 25% per year over four years, with a ten-year life. The Company determined the fair value of stock options granted during the nine months ended September 30, 2021 is based upon assumptions as provided below.

 

  

June 2021 Grant

  

3rd quarter 2021 Grant

 
  

150,000 Stock Options

  

178,500 Stock Options

 

Stock Price

 $4.26  $4.01 

Exercise Price

 $4.26  $4.01 

Dividend yield

  0%  0%

Expected volatility

  67%  67%

Risk-Free interest rate

  1.35%  1.35%

Expected life (in years)

  6.00   6.00 

 

The Company has a total of 738,500 outstanding stock options, of which 390,000 were exercisable under the three plans at September 30, 2021.

 

The following table summarizes information about the outstanding and exercisable options at September 30, 2021.

 

      

Options Outstanding

  

Options Exercisable

 
          

Weighted

  

Weighted

          

Weighted

     
          

Average

  

Average

          

Average

     

Exercise

  

Number

  

Remaining

  

Exercise

  

Intrinsic

  

Number

  

Exercise

  

Intrinsic

 

Price Range

  

Outstanding

  

Contractual

  

Price

  

Value

  

Exercisable

  

Price

  

Value

 
$4.00-7.00   373,500   9.6  $4.13  $149,000   45,000  $5.00  $0 
$7.01-10.00   20,000   6.6  $8.07  $0   20,000  $8.07  $0 
$10.01-12.00   220,000   2.1  $10.81  $0   200,000  $10.87  $0 
$12.01-15.00   125,000   .7  $15.00  $0   125,000  $15.00  $0 

 

 

No options were exercised during the nine months ended September 30, 2021. As of September 30, 2021, there was $772,000 of unrecognized compensation costs related to stock options expected to be recognized over a weighted average period of 3.6 years.

 

Restricted Stock Awards

 

The following table summarizes restricted stock awards for the nine months ended September 30, 2021:

 

  

Shares of

Restricted

Stock

  

Weighted

Average Grant

Date Fair

Value

 

Unvested outstanding at December 31, 2020

  -   - 

Granted

  42,800  $4.65 

Vested

  -   - 

Forfeited/Cancelled

  (7,646) $4.90 

Unvested outstanding at September 30, 2021

  35,154  $4.59 

 

 

The fair value of the outstanding restricted stock awards will be recorded as stock compensation expense over the vesting period. As of September 30, 2021, there was $37,000 of total unrecognized compensation costs related to restricted stock awards, which is expected to be recognized over a weighted-average period of .25 years.

 

Restricted Stock Units

 

The following table summarizes activity related to outstanding restricted stock units for the nine months ended September 30, 2021:

 

      

Weighted

 
  

Shares of

  

Average Grant

 
  

Restricted

  

Date Fair

 
  

Stock Units

  

Value

 

Unvested outstanding at December 31, 2020

  8,750  $5.00 

Granted

  2,333  $5.36 

Vested

  (5,583) $5.32 

Forfeited/Cancelled

  -  $- - 
         

Unvested outstanding at September 30, 2021

  5,500  $4.83 

 

 

The total fair value of vested restricted stock units was $29,700 for the nine months ended September 30, 2021.

 

The fair value of the outstanding restricted stock units will be recorded as stock compensation expense over the vesting period. As of September 30, 2021, there was $10,000 of total unrecognized compensation costs related to restricted stock units, which is expected to be recognized over a weighted-average period of .4 years.